At the immunohistochemical level, fibrolamellar carcinoma is characterized by cytokeratin 71, 2 and CD68 co-expression.3 These immunostains are useful to support the diagnosis of fibrolamellar carcinoma. This evidence concerns the gene CD68 and fibrolamellar hepatocellular carcinoma.